BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 4050756)

  • 1. Significance of a gastric mass screening survey.
    Shiratori Y; Nakagawa S; Kikuchi A; Ishii M; Ueno M; Miyashita T; Sakurai T; Negami J; Suzuki T; Sato I
    Am J Gastroenterol; 1985 Nov; 80(11):831-4. PubMed ID: 4050756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [End results of gastric cancer detected by mass survey: analysis using the relative survival rate curve].
    Arisue T; Tamura K; Tebayashi A
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):929-36. PubMed ID: 3389836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of early esophageal and gastric cancers by mass screening].
    Mitsunaga N; Tsubouchi H
    Nihon Rinsho; 1996 May; 54(5):1415-20. PubMed ID: 8965377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early screening of cancer of the stomach in Japan].
    Murata I; Clot JP; Sakabe T
    J Chir (Paris); 1987 Jan; 124(1):35-8. PubMed ID: 3558513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of gastric cancer detected by mass screening.
    Hanazaki K; Sodeyama H; Wakabayashi M; Miyazawa M; Yokoyama S; Sode Y; Kawamura N; Miyazaki T; Ohtsuka M
    Hepatogastroenterology; 1997; 44(16):1126-32. PubMed ID: 9261611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of gastric cancer detected by mass survey. Comparison with those of outpatients].
    Fujii A; Masuda Y
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):937-43. PubMed ID: 3389837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study on the efficiency of gastric cancer screening, with special reference to the appropriate frequency of screening].
    Kohrogi N
    Fukuoka Igaku Zasshi; 1987 Feb; 78(2):67-81. PubMed ID: 3583202
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population.
    Miki K; Fujishiro M; Kodashima S; Yahagi N
    Dig Endosc; 2009 Apr; 21(2):78-81. PubMed ID: 19691778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of screening survey of gastric cancer on clinicopathological features and survival: retrospective study at a single institution.
    Kubota H; Kotoh T; Masunaga R; Dhar DK; Shibakita M; Tachibana M; Kohno H; Nagasue N
    Surgery; 2000 Jul; 128(1):41-7. PubMed ID: 10876184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of gastric mass screening in Japan.
    Hisamichi S; Sugawara N; Fukao A
    Cancer Detect Prev; 1988; 11(3-6):323-9. PubMed ID: 3390854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of gastric mass survey.
    Okui K; Tejima H
    Acta Chir Scand; 1980; 146(3):185-7. PubMed ID: 7468039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
    Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
    Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of mass screening for gastric carcinoma.
    Kunisaki C; Ishino J; Nakajima S; Motohashi H; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
    Ann Surg Oncol; 2006 Feb; 13(2):221-8. PubMed ID: 16411143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
    Yanaoka K; Oka M; Mukoubayashi C; Yoshimura N; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Ohata H; Fujishiro M; Takeshita T; Mohara O; Ichinose M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):838-45. PubMed ID: 18398025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inspection for gastric occult blood at regular intervals is the optimum program for the screening of esophageal-gastric cancer.
    Qin D; Wang G; Zhang X; Zuo J; Yuan F; Li M; Geng C; Wang L; Jv C; Chen J
    Ann Ital Chir; 1995; 66(1):41-4; discussion 45-6. PubMed ID: 7668481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinico-pathological study of gastric cancer in the greater curvature].
    Yamagiwa H; Yoshimura H; Tomiyama H; Onishi T; Matsuzaki O
    Gan No Rinsho; 1983 Jul; 29(8):891-6. PubMed ID: 6887521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is gastric carcinoma different between Japan and the United States?
    Noguchi Y; Yoshikawa T; Tsuburaya A; Motohashi H; Karpeh MS; Brennan MF
    Cancer; 2000 Dec; 89(11):2237-46. PubMed ID: 11147594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic screening for gastric cancer.
    Dan YY; So JB; Yeoh KG
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics and progress of treatment for gastric cancers detected by mass screening].
    Muta Y; Baba Y; Nishiyama M; Bandou K; Ogata S; Sakaguti K
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1505-13. PubMed ID: 9725041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.